Cyrus Harmon, CHIEF TECHNOLOGY OFFICER at Olema Pharmaceuticals, Inc. (OLMA), sold 400 shares at $24.76 ($10K) on 2021-11-29, disclosed to the SEC on 2021-12-01.
Scheduled sale ($10k) by CHIEF TECHNOLOGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |